scispace - formally typeset
Open AccessJournal ArticleDOI

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

TLDR
It is demonstrated that SARS-CoV-2 uses the SARS -CoV receptor ACE2 for entry and the serine protease TMPRSS2 for S protein priming, and it is shown that the sera from convalescent SARS patients cross-neutralized Sars-2-S-driven entry.
About
This article is published in Cell.The article was published on 2020-04-16 and is currently open access. It has received 15362 citations till now. The article focuses on the topics: Proteases.

read more

Citations
More filters
Journal ArticleDOI

D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease Cleavage at the S1/S2 Junction.

TL;DR: In this article, the effects of the D614G mutation on a soluble S ectodomain construct were explored and the results elucidate SARS-CoV-2 conformational landscape and allostery and have implications for vaccine design.
Journal ArticleDOI

Human iPSC-Derived Cardiomyocytes , are Susceptible to SARS-CoV-2 Infection

TL;DR: It is shown that SARS-CoV-2 can infect hiPSC-CMs in vitro, establishing a model for elucidating infection mechanisms and potentially a cardiac-specific antiviral drug screening platform.
Journal ArticleDOI

COVID-19 and immunomodulation in IBD.

TL;DR: The current understanding of the pathophysiology of COVID-19 is reviewed with special reference to immune cell activation and the potential implications of these new insights for immunomodulation and biological therapy in IBD are discussed.
Posted Content

Network Medicine Framework for Identifying Drug Repurposing Opportunities for COVID-19

TL;DR: Three network-based drug repurposing strategies are deployed, relying on network proximity, diffusion, and AI-based metrics, allowing to rank all approved drugs based on their likely efficacy for COVID-19 patients, and aggregate all predictions, to arrive at 81 promising repurpose candidates.
Journal ArticleDOI

SARS-CoV-2 pathogenesis

TL;DR: In this paper , the authors explore recent clinical and experimental advances regarding SARS-CoV-2 pathophysiology and discuss potential mechanisms behind acute respiratory distress syndrome (ARDS), specifically focusing on new insights obtained using novel technologies such as single-cell omics, organoid infection models and CRISPR screens.
References
More filters
Journal ArticleDOI

MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms.

TL;DR: The Molecular Evolutionary Genetics Analysis (Mega) software implements many analytical methods and tools for phylogenomics and phylomedicine and has additionally been upgraded to use multiple computing cores for many molecular evolutionary analyses.
Journal ArticleDOI

A Novel Coronavirus from Patients with Pneumonia in China, 2019.

TL;DR: Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans.
Journal ArticleDOI

A pneumonia outbreak associated with a new coronavirus of probable bat origin

TL;DR: Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Related Papers (5)